Improving diagnostics and care for first suspected epileptic seizures
EPI-NY: Improving Diagnostics and Care After First Seizure
Haukeland University Hospital · NCT06814665
This study is trying to see how common first suspected seizures are in Bergen, Norway, and how to better diagnose and care for people experiencing these events.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Sex | All |
| Sponsor | Haukeland University Hospital (other) |
| Locations | 1 site (Bergen) |
| Trial ID | NCT06814665 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the prevalence of first seizure-like events in Bergen, Norway, and to investigate the clinical trajectory of patients before and after an epilepsy diagnosis. It focuses on individuals who have experienced events suspected to be epileptic seizures, including those who have not yet been evaluated by a neurologist. The study will utilize EEG as a key diagnostic tool, alongside advancements in artificial intelligence to enhance diagnostic accuracy. By establishing a first seizure clinic, the study seeks to improve early diagnostics and alleviate the uncertainty surrounding epilepsy diagnoses.
Who should consider this trial
Good fit: Ideal candidates include individuals who have experienced a first suspected epileptic seizure or recurrent seizure-like events that have not been adequately evaluated.
Not a fit: Patients who have already received a definitive epilepsy diagnosis or those with seizure events that have been thoroughly evaluated and ruled out as epileptic may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic processes and care for patients experiencing their first suspected epileptic seizure.
How similar studies have performed: While first seizure clinics are becoming more common globally, this specific approach in Norway is novel and has not been previously tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patient has experienced events with a substantial suspicion of being an epileptic seizure. One of: * The patient has experienced one or more first-in-life events with a substantial suspicion of being an epileptic seizure, including febrile seizures, and these episodes have previously not been evaluated by a neurologist or pediatrician OR * The patient has experienced the recurrence of events with a substantial suspicion of being an epileptic seizure, that have previously been evaluated by a neurologist or pediatrician to not be epileptic, and this merits a new evaluation. * OR: The patient does not fulfill the criteria above, but has been investigated for episodes or complaints, which after evaluation have been shown to be first-in-life epileptic seizures. OR -The patient has experienced the recurrence of events with a substantial suspicion of being an epileptic seizure, that have previously been evaluated by a neurologist or pediatrician to not be epileptic, and this merits a new evaluation. Exclusion Criteria: * Previous known clinical diagnosis of epilepsy given by a neurologist or pediatrician, and not subsequently retracted. * Person or caregivers able to give informed consent. * Adequate Norwegian language skills to be able to fill out questionnaires.
Where this trial is running
Bergen
- Haukeland University Hospital — Bergen, Norway (RECRUITING)
Study contacts
- Principal investigator: Jan Brogger, MD PhD — Helse-Bergen HF
- Study coordinator: Jan Brøgger, MD PhD
- Email: jan.brogger@helse-bergen.no
- Phone: 4755975058
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: First Suspected Epileptic Seizure, epilepsy, first seizure, early epilepsy, EEG, AI